Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04855045
Status:
UNKNOWN
Last Update Posted:
2022-03-25
First Post:
2021-04-13
Brief Title:
An Open-label Dose Escalation and Double-masked Randomized Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children 8 Years of Age With LCA10 Caused by Mutations in the CEP290 Gene
Sponsor:
ProQR Therapeutics
Organization:
ProQR Therapeutics
Organization Data
Organization:
ProQR Therapeutics
Class:
INDUSTRY
Study ID:
PQ-110-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ProQR Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None